Ironwood Pharmaceuti (IRWD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 351,410 | 442,735 | 410,596 | 413,753 | 389,523 |
| Cost of Goods | N/A | N/A | N/A | N/A | 3,136 |
| Gross Profit | 351,410 | 442,735 | 410,596 | 413,753 | 386,387 |
| Operating Expenses | 258,286 | 1,388,165 | 160,259 | 181,494 | 243,583 |
| Operating Income | 93,124 | -945,430 | 250,337 | 232,259 | 142,940 |
| Interest Expense | 33,034 | 21,629 | 7,598 | 31,150 | 29,478 |
| Other Income | 5,108 | 18,990 | 9,683 | -452 | -4,601 |
| Pre-tax Income | 65,198 | -948,069 | 252,422 | 200,657 | 108,861 |
| Income Tax | 64,318 | 83,490 | 77,357 | -327,791 | 2,685 |
| Net Income Continuous | 880 | -1,031,559 | 175,065 | 528,448 | 106,176 |
| Minority Interests | N/A | -29,320 | N/A | N/A | N/A |
| Net Income | $880 | $-1,002,239 | $175,065 | $528,448 | $106,176 |
| EPS Basic Total Ops | 0.01 | -6.45 | 1.13 | 3.26 | 0.67 |
| EPS Basic Continuous Ops | 0.01 | -6.64 | 1.13 | 3.26 | 0.67 |
| EPS Diluted Total Ops | 0.01 | -6.45 | 0.96 | 3.21 | 0.66 |
| EPS Diluted Continuous Ops | 0.01 | -6.64 | 0.94 | 3.21 | 0.66 |
| EPS Diluted Before Non-Recurring Items | 0.04 | -6.27 | 0.96 | 1.16 | 0.79 |
| EBITDA(a) | $95,135 | $-943,855 | $251,755 | $233,782 | $146,504 |